Combined Holdings of CRISPR Therapeutics (CRSP) - Updated Daily
TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 0% | $3.87b |
| 🏋️♀️Weight Rank Across All Funds | 🌏Country |
| 201 | 🇨🇭Switzerland |
| 💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
$70.01 - ARKG$62.32 - ARKK | 2.14% |
Other ETFs That Hold CRSP
Research Notes and Commentary for CRSP
No Research Notes Found for CRSP